Download PDF
Drug Res (Stuttg)
DOI: 10.1055/a-2308-9192
Original Article

Synergistic anxiolytic efficacy exploring the combined effects of diazepam and zinc chloride in wistar albino rats

Vishwani V. Naik 
1   Department of Pharmacology, Goa College of Pharmacy, Goa University, Panjim, Goa, India
,
Vedita Hegde Desai
1   Department of Pharmacology, Goa College of Pharmacy, Goa University, Panjim, Goa, India
,
Sam Noronha
1   Department of Pharmacology, Goa College of Pharmacy, Goa University, Panjim, Goa, India
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Combinations of medications are frequently employed when their effects are similar. Beyond aiding in the reduction of medication dosages, this approach may yield additional positive outcomes. Studies have shown that zinc can mitigate anxiety-related behavior in laboratory animals. This study aimed to investigate the potential stabilizing effects of zinc chloride and diazepam in Wistar albino rats.

Five groups, each comprising six animals. Test groups included two combinations of zinc chloride and diazepam, each with two different doses of diazepam (1 and 2 mg/kg) and 10 mg/kg of zinc chloride. Four established anxiety models—the Elevated Plus Maze (EPM), the hole board, the light and dark box, and the mirror chamber—were employed to assess the anxiolytic effects. The combination of zinc chloride and diazepam proved to be more effective than the individual doses of zinc chloride and diazepam, indicating enhanced anxiolytic effects.

Keywords

elevated plus maze - synergism - hole board - light and dark - zinc - anxiety


Publication History

Received: 22 January 2024

Accepted: 16 April 2024

Article published online:
10 May 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Dobson KS. The relationship between anxiety and depression. Clin Psychol Rev 1985; 5: 307-324 DOI: 10.1016/0272-7358(85)90010-8.
    CrossrefPubMedGoogle Scholar
  • 2 Trivedi JK, Gupta PK. An overview of Indian research in anxiety disorders. Indian J Psychiatry [Internet] 2010; [cited 2021 Oct 15] 52: S210-S218 Available from: https://pubmed.ncbi.nlm.nih.gov/21836680
    CrossrefPubMedGoogle Scholar
  • 3 Wesson DR, Smith DE, Ling W. et al. Substance Abuse: Sedative, Hypnotic, or Anxiolytic Use Disorders. Psychiatry 2008; 1186-1200 Available from: https://doi.org/10.1002/9780470515167.ch64
    CrossrefPubMedGoogle Scholar
  • 4 Barker MJ, Greenwood KM, Jackson M. et al. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18: 37-48
    CrossrefPubMedGoogle Scholar
  • 5 Cavalcanti CL, Gonçalves MCR, Alves AF. et al. Antidepressant, Anxiolytic and Neuroprotective Activities of Two Zinc Compounds in Diabetic Rats. Front Neurosci 2020; 13: 1411 Available from: https://pubmed.ncbi.nlm.nih.gov/32038128
    CrossrefPubMedGoogle Scholar
  • 6 Starcevic V. Benzodiazepines for anxiety disorders: Maximising the benefits and minimising the risks. Adv Psychiatr Treat 2012; 18: 250-258
    CrossrefPubMedGoogle Scholar
  • 7 Bystritsky A, Khalsa SS, Cameron ME. et al. Current diagnosis and treatment of anxiety disorders. 2013 38. 30-57 Available from: https://pubmed.ncbi.nlm.nih.gov/23599668
    PubMedGoogle Scholar
  • 8 Trumbo P, Yates AA, Schlicker S. et al. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001; 101: 294-301
    CrossrefPubMedGoogle Scholar
  • 9 Basharat S, Qamar MM. Beneficial effects of zinc on reducing severity of depression. 2019 10. 135-139
    PubMedGoogle Scholar
  • 10 Russo AJ. Decreased Zinc and Increased Copper in Individuals with Anxiety. Nutr Metab Insights 2011; 4 NMI S6349
    CrossrefPubMedGoogle Scholar
  • 11 Mocchegiani E, Santarelli L, Muzzioli M. et al. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice. Int J Immunopharmacol 1995; 17: 703-718
    CrossrefPubMedGoogle Scholar
  • 12 Szewczyk B, Poleszak E, Sowa-Kućma M. et al. Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 2008; 60: 588-589
    PubMedGoogle Scholar
  • 13 Tekuri SK, Purusotham Bassaiahgari, Yuvaranjani Gali1 SRA, Pabbaraju N. Determination of Median Lethal Dose of Zinc chloride in Wistar Rat. Adv Anim Vet Sci 2021 14. 389-395
    PubMed
  • 14 Kumar V, Kumar A, Singh K. et al. Neurobiology of zinc and its role in neurogenesis. Eur J Nutr 2021; 60: 55-64
    CrossrefPubMedGoogle Scholar
  • 15 Tallarida RJ. Quantitative methods for assessing drug synergism. Genes Cancer 2011; 2: 1003-1008
    CrossrefPubMedGoogle Scholar
  • 16 Anandan I, Selvaraj N, Meenakshi R. et al. Synergistic Anxiolytic Effect of Curcumin and Zinc on Acute and Chronic Models of Anxiety in Mice. J Clin Diagnostic Res 2020; 14: 12-15
    PubMedGoogle Scholar
  • 17 Dayan AD. Drug Discovery and Evaluation edited by HG Vogel and WH Vogel. 1998
    PubMedGoogle Scholar
  • 18 Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007; 2: 322-328
    CrossrefPubMedGoogle Scholar
  • 19 Bourin M, Hascoët M. The mouse light/dark box test. Eur J Pharmacol 2003; 463: 55-65
    CrossrefPubMedGoogle Scholar
  • 20 Toubas PL, Abla KA, Cao W. et al. Latency to enter a mirrored chamber: a novel behavioral assay for anxiolytic agents. Pharmacol Biochem Behav 1990; 35: 121-126
    CrossrefPubMedGoogle Scholar
  • 21 Gallup GGJ. Mirror-image stimulation. Psychol Bull 1968; 70: 782-793
    CrossrefPubMedGoogle Scholar